Two Sigma Advisers LP boosted its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 21.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 182,500 shares of the real estate investment trust's stock after acquiring an additional 32,100 shares during the quarter. Two Sigma Advisers LP owned about 0.08% of Sabra Health Care REIT worth $3,161,000 as of its most recent filing with the SEC.
Several other large investors have also recently bought and sold shares of the business. Assetmark Inc. raised its position in Sabra Health Care REIT by 33.4% in the fourth quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust's stock worth $45,000 after acquiring an additional 656 shares in the last quarter. Janney Montgomery Scott LLC raised its position in Sabra Health Care REIT by 0.4% in the fourth quarter. Janney Montgomery Scott LLC now owns 177,161 shares of the real estate investment trust's stock worth $3,068,000 after acquiring an additional 763 shares in the last quarter. Focus Partners Wealth raised its position in Sabra Health Care REIT by 4.0% in the fourth quarter. Focus Partners Wealth now owns 20,771 shares of the real estate investment trust's stock worth $360,000 after acquiring an additional 797 shares in the last quarter. Louisiana State Employees Retirement System raised its position in Sabra Health Care REIT by 1.2% in the fourth quarter. Louisiana State Employees Retirement System now owns 65,700 shares of the real estate investment trust's stock worth $1,138,000 after acquiring an additional 800 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund raised its position in Sabra Health Care REIT by 1.7% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 48,185 shares of the real estate investment trust's stock worth $835,000 after acquiring an additional 800 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company's stock.
Sabra Health Care REIT Price Performance
Sabra Health Care REIT stock traded up $0.02 during trading hours on Thursday, hitting $17.42. The stock had a trading volume of 2,099,914 shares, compared to its average volume of 2,209,622. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The stock has a market capitalization of $4.14 billion, a price-to-earnings ratio of 32.87, a PEG ratio of 1.97 and a beta of 0.88. Sabra Health Care REIT, Inc. has a 1-year low of $13.87 and a 1-year high of $20.03. The stock's fifty day moving average is $17.53 and its two-hundred day moving average is $17.36.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.01. The company had revenue of $183.54 million for the quarter, compared to analyst estimates of $180.23 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. Sabra Health Care REIT's revenue was up 10.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.35 earnings per share. As a group, analysts predict that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current fiscal year.
Sabra Health Care REIT Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 30th. Investors of record on Friday, May 16th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.89%. The ex-dividend date is Friday, May 16th. Sabra Health Care REIT's payout ratio is currently 203.39%.
Analysts Set New Price Targets
Several research analysts have issued reports on SBRA shares. Truist Financial increased their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a research report on Tuesday, March 18th. Scotiabank increased their price objective on Sabra Health Care REIT from $18.00 to $19.00 and gave the stock a "sector perform" rating in a research report on Monday, May 12th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $19.50.
Read Our Latest Analysis on Sabra Health Care REIT
Insider Activity at Sabra Health Care REIT
In related news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the sale, the director now owns 64,725 shares of the company's stock, valued at $1,179,289.50. This trade represents a 14.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.10% of the company's stock.
Sabra Health Care REIT Company Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Articles

Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.